1. Acknowledgement

   Acknowledgments 24 September 2012 Pages: 2375 - 2379

2. Gastro-Oesophageal Reflux Disease

   • Tiberiu Hershcovici
   • Ronnie Fass

   Current Opinion 24 September 2012 Pages: 2381 - 2389

   

3. Erratum to: Eldecalcitol: a review of its use in the treatment of osteoporosis

   • M. Sanford
   • P. L. McCormack

   Erratum 24 September 2012 Pages: 2390 - 2390

4. Epigenetic-Based Therapies in Cancer

   • Sang-Hyun Song
   • Sae-Won Han
   • Yung-Jue Bang

   Leading Article 24 September 2012 Pages: 2391 - 2403

   

5. Triazole Antifungal Agents in Invasive Fungal Infections

   • Cornelia Lass-Flörl

   Review Article 24 September 2012 Pages: 2405 - 2419

   

6. Use of Herbal Medicines and Nutritional Supplements in Ocular Disorders

   • Justin T. Wilkinson
   • Frederick W. Fraunfelder

   Review Article 24 September 2012 Pages: 2421 - 2434

   

7. Belimumab

   • Celeste B. Burness
   • Paul L. McCormack

   Adis Drug Profile 24 September 2012 Pages: 2435 - 2444

   

8. Fidaxomicin

   • Sean T. Duggan

   Adis Drug Profile 24 September 2012 Pages: 2445 - 2456

   

9. Celecoxib

   • Paul L. McCormack

   Adis Drug Evaluation 24 September 2012 Pages: 2457 - 2489

   

10. Buprenorphine 5, 10 and 20 μg/h Transdermal Patch

    • Greg L. Plosker

    Adis Drug Evaluation 24 September 2012 Pages: 2491 - 2509

    

11. Entecavir

    • Gillian M. Keating

    Adis Drug Evaluation 24 September 2012 Pages: 2511 - 2529

    

12. Pegylated Liposomal Doxorubicin

    • Sean T. Duggan
    • Gillian M. Keating

    Adis Drug Evaluation 24 September 2012 Pages: 2531 - 2558